2812 Results (Page 1 of 235)
Pharmaceuticals Markets Research Reports
US Advanced Therapy Medicinal Products (ATMPs) Market Analysis
The US Advanced Therapy Medicinal Products (ATMPs) market is projected to grow from $4.3 Bn in 2022 to $9.8 Bn by 2030, registering a CAGR of 11% during the forecast period of 2022-30. One of the key drivers of growth in the US ATMP market is the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases. These diseases often require long-term treatment, and ATMPs offer a promising new approach to treating them. Additionally, advances in gene editing technologies such as CRISPR/Cas9 have increased the potential for ATMPs to cure genetic disorders. Some of the major players are Novartis International AG, Gilead Sciences, Inc., Bluebird Bio, Inc., Spark Therapeutics, Inc., and Kite Pharma, Inc.
UK Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the UK Lung Cancer Therapeutics Market will reach a value of $1245 Mn from $775 Mn in 2022, growing at a CAGR of 6.1% during 2022-30. The Lung Cancer Therapeutics Market in the UK is dominated by a few domestic pharmaceutical companies such as Scancell, Sareum Holdings, and AstraZeneca. The Lung Cancer Therapeutics Market in the UK is segmented into different types of cancer and different therapy types. Some of the major factors affecting the UK lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
UK Diabetes Therapeutics Market Analysis
The UK diabetes therapeutics market is expected to grow from $3.74 Bn in 2022 to $6.77 Bn in 2030 with a CAGR of 7.7% for the forecasted year 2022-30. The rising incidence of diabetes and the subsequent demand for new and innovative treatment options for diabetes in the UK is driving the growth of the market. The UK diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Tanner Pharma, Bracco, and AstraZeneca are the major players in the UK diabetes therapeutics market.
UK Cardiovascular Drugs Market Analysis
This report presents a strategic analysis of the UK Cardiovascular Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UK Cardiovascular Drugs Market, offering unmatched value, accuracy and expert insights.
UAE Pharmaceutical Market Analysis
This report presents a strategic analysis of the UAE Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UAE Pharmaceutical Market, offering unmatched value, accuracy and expert insights.
Turkey Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the Turkey Oncology Therapeutics Market will reach a value of $2.8 Bn from $1.5 Bn in 2022, growing at a CAGR of 8.9% during 2022-2030. The Oncology Therapeutics Market in Turkey is dominated by a few domestic pharmaceutical companies such as Deva Holding, Mustafa Nevzat, and Abdi İbrahim. The Oncology Therapeutics Market in Turkey is segmented into different types of cancer and different therapy types. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Turkey Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
Turkey Oncology Drugs Market Analysis
This report presents a strategic analysis of the Turkey Oncology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Turkey Oncology Drugs Market, offering unmatched value, accuracy and expert insights.
Thailand Sleep Disorders Market Analysis
This report presents a strategic analysis of the Thailand Sleep Disorders Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Thailand Sleep Disorders Market, offering unmatched value, accuracy and expert insights.
Thailand Cancer Immunotherapy Market Analysis
Thailand's cancer immunotherapy market is expected to witness growth from $135 Mn in 2022 to $240 Mn in 2030 with a CAGR of 7.4% for the forecasted year 2022-30. The increasing incidence of cancer and the improvements in healthcare spending in Thailand are responsible for the growth of the market. The Thailand cancer immunotherapy market is segmented by type, application, and end user. Silom Medical, Emergpharma, and Bayer are the major players in the Thailand cancer immunotherapy market.
Thailand Breast Cancer Therapeutics Market Analysis
Thailand's breast cancer therapeutics is expected to witness a rise in the market size from $xx Bn in 2022 to $xx Bn in 2030 with a CAGR of xx% for the year 2022-30 due to market drivers like changing lifestyle choices ultimately leading to breast cancer and high mortality ratios associated with breast cancer in Thailand. The market is segmented by therapy, by cancer type, and by distribution channel. ON Tanakit, Pfizer, and Bayer AG are some of the key players in the Thailand breast cancer therapeutics market.
Thailand Acne Therapeutics Market Analysis
This report presents a strategic analysis of the Thailand Acne Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Thailand Acne Therapeutics Market, offering unmatched value, accuracy and expert insights.
Switzerland Dermatology Drugs Market Analysis
By 2030, it is anticipated that the Switzerland Dermatology drugs market will reach a value of $xx Mn from $xx Mn in 2022, growing at a CAGR of xx% during 2022-30. The market is primarily dominated by local players such as STADA Arzneimittel, Actelion Pharmaceuticals, and Medartis. The market is driven by government regulations and improved health indicators in the country. The dermatology drug market in Switzerland is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.
Spain Vitamin and Minerals Market Analysis
This report presents a strategic analysis of the Spain Vitamin and Minerals Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Spain Vitamin and Minerals Market, offering unmatched value, accuracy and expert insights.
Spain Oral Care Market Analysis
Spain's oral care market was valued at $680 Mn in 2022 and is estimated to expand at a CAGR of 5.2% from 2022-30 and will reach $1020 Mn in 2030. One of the main reasons propelling the growth of this market is the rising demand for premium oral care products and the ageing population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Vitaldent, Adeslas Dental, Sanitas Dental, Dentsply Sirona, BioHorizons, Kerr, GC Europe, Septodont, and Sirona.
South Korea Diabetes Therapeutics Market Analysis
South Korean diabetes therapeutics market is expected to witness growth from $2.1 Bn in 2022 to $4.7 Bn in 2030 with a CAGR of 10.7% for the forecasted year 2022-30. The increase in the prevalence of diabetes in South Korea, as well as government policies designed to promote awareness of diabetes in South Korea, are the major market drivers. The South Korean diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Chong Kun Dang, Kwang Dong Pharmaceutical, and Boehringer Ingelheim are the major players in the South Korean diabetes therapeutics market.
South Africa Women's Health Market Analysis
This report presents a strategic analysis of the South Africa Women's Health Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the South African women's Health Market, offering unmatched value, accuracy and expert insights.
South Africa Oncology Drugs Market Analysis
This report presents a strategic analysis of the South Africa Oncology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the South Africa Oncology Drugs Market, offering unmatched value, accuracy and expert insights.
UAE Retail Pharmacy Market Analysis
The UAE Retail Pharmacy Market is projected to grow from $5.193 Bn in 2022 to $9.541 Bn by 2030, registering a CAGR of 7.9% during the forecast period of 2022-2030. The market is expected to continue growing at a steady pace in the coming years, with an increasing number of retail pharmacy chains and independent pharmacies opening in the country. Lloyds Pharmacy is a leading retail pharmacy chain in the UAE, with over 70 branches across the country.
South Africa Cancer Immunotherapy Market Analysis
South Africa's cancer immunotherapy market is expected to witness growth from $731 Mn in 2022 to $1,387 Mn in 2030 with a CAGR of 8.3% for the forecasted year 2022-30. The rising incidence of cancer in South Africa along with supportive government policies to make the immunotherapies accessible to the patients in South Africa are driving the growth of the market. The South African cancer immunotherapy market is segmented by type, application, and end user. Xenia Pharmaceutical, Austell Pharmaceuticals, and Bristol-Myers Squibb are the major players in the South African cancer immunotherapy market.
Singapore Pharmaceutical Market Analysis
This report presents a strategic analysis of the Singapore Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Pharmaceutical Market, offering unmatched value, accuracy and expert insights.
Singapore Cardiovascular Diseases Therapeutics Market Analysis
Singapore's cardiovascular disease therapeutics market is expected to witness growth from $195 Mn in 2022 to $356 Mn in 2030 with a CAGR of 7.82% for the forecasted year 2022-30. due to the rising prevalence of cardiovascular diseases in Singapore along with the increase in demand for novel therapeutic options for treatment are the major market drivers for the market. The Singapore cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by end user. iNova Pharmaceuticals, Eshcol Pharmaceutical, and Zydus are the major players in the Singapore cardiovascular disease therapeutics market.
Saudi Arabia Orphan Diseases Drugs Market Analysis
This report presents a strategic analysis of the Saudi Arabia Orphan Diseases Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Saudi Arabian Orphan Diseases Drugs Market, offering unmatched value, accuracy and expert insights.
Saudi Arabia Infectious Disease Drugs Market Analysis
This report presents a strategic analysis of the Saudi Arabia Infectious Disease Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Saudi Arabia Infectious Disease Drugs Market, offering unmatched value, accuracy and expert insights.
Romania Diabetes Therapeutics Market Analysis
Romania's diabetes therapeutics market is expected to witness growth from $417 Mn in 2022 to $891 Mn in 2030 with a CAGR of 9.95% for the forecasted year 2022-30. The growing prevalence of diabetes and consequently the rising demand for novel therapeutic options in Romania are responsible for the growth of the market. The Romania diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Cegedim, Magistra, and Eli Lilly are the major players in the Romania diabetes therapeutics market.
Saudi Arabia Cancer Immunotherapy Market Analysis
Saudi Arabia's cancer immunotherapy market is expected to witness growth from $1.9 Bn in 2022 to $3.7 Bn in 2030 with a CAGR of 8.6% for the forecasted year 2022 to 2030. The rising demand for immunotherapy treatments and rapid approvals for immunotherapy drugs in Saudi Arabia is responsible for the growth of the market. The Saudi Arabia cancer immunotherapy market is segmented by type, application, and end user. Jamjoom Pharma, Damman Pharma, and Merck are the major players in the Saudi Arabia cancer immunotherapy market.